Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: A review

Cellular and Molecular Neurobiology

Volumn 29, Issue 6-7, 2009, Pages 1025-1035

  Gál, Peter ^a   Kravčuková, Petra ^b   Mokrý, Michal ^a,c   Kluchová, Darina ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c HUBRECHT INSTITUTE   (Netherlands)

Author keywords

Antagonist; Chemokine ligand; Chemokine receptor; Inflammation model; Regeneration

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; 1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; 1 ACETYL N [3 [4 (4 CARBAMOYLBENZYL) 1 PIPERIDINYL]PROPYL] N (3 CHLORO 4 METHYLPHENYL) 4 PIPERIDINECARBOXAMIDE; 4 [(4 BROMOPHENYL)(ETHOXYIMINO)METHYL] 1' [(2,4 DIMETHYL 3 PYRIDINYL)CARBONYL] 4' METHYL 1,4' BIPIPERIDINE; 8 [4 (2 BUTOXYETHOXY)PHENYL] 1,2,3,4 TETRAHYDRO 1 ISOBUTYL N [4 (1 PROPYL 1H IMIDAZOL 5 YLMETHYLSULFINYL)PHENYL] 1 BENZAZOCINE 5 CARBOXAMIDE; AK 608; AMD 2763; AMD 3451; AMG 487; ANIBAMINE; APLAVIROC; BMS 570520; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CP 481715; DPC 168; EOTAXIN 3; INCB 3344; IS 811; JNJ 27553292; MARAVIROC; MC 148; METHYLPREDNISOLONE; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; NBI 74330; PLERIXAFOR; SB 297006; SB 328437; SB 656933; SCH 527123; T 134; T 22; UCB 35625; UNCLASSIFIED DRUG; UNINDEXED DRUG; VICRIVIROC; YM 355179;

ANIMAL MODEL; ARTICLE; CELL THERAPY; CYTOKINE RELEASE; INFLAMMATION; NERVE FIBER GROWTH; NONHUMAN; OXIDATIVE STRESS; PARAPLEGIA; PRIORITY JOURNAL; PROTEIN SECRETION; QUADRIPLEGIA; REMYELINIZATION; SPINAL CORD INJURY;

ACUTE DISEASE; ANIMALS; CHEMOKINES; HUMANS; IMMUNOTHERAPY; INFLAMMATION; SECONDARY PREVENTION; SPINAL CORD INJURIES;

EID: 68149131621     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9392-4     Document Type: Article

References (107)

1. YH Ahn G Lee SK Kang 2006 Molecular insights of the injured lesions of rat spinal cords: inflammation, apoptosis, and cell survival Biochem Biophys Res Commun 348 560 570 10.1016/j.bbrc.2006.07.105 (Pubitemid 44188602)
2. AP Amar ML Levy 1999 Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury Neurosurgery 44 1027 1039 10.1097/00006123-199905000-00052 (Pubitemid 29202863)
3. R Arakaki H Tamamura M Premanathan K Kanbara S Ramanan K Mochizuki M Baba N Fujii H Nakashima 1999 T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure J Virol 73 1719 1723
4. M Baba O Nishimura N Kanzaki M Okamoto H Sawada Y Iizawa M Shiraishi Y Aramaki K Okonogi Y Ogawa K Meguro M Fujino 1999 A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity Proc Natl Acad Sci USA 96 5698 5703 10.1073/pnas.96.10.5698 (Pubitemid 29234681)
5. PJ Barnes 2006 How corticosteroids control inflammation: Quintiles Prize Lecture 2005 Br J Pharmacol 148 245 254 10.1038/sj.bjp.0706736 (Pubitemid 43804814)
6. DM Basso MS Beattie JC Bresnahan 1996 Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection Exp Neurol 139 244 256 10.1006/exnr.1996.0098 (Pubitemid 26228093)
7. DL Behrmann JC Bresnahan MS Beattie BR Shah 1992 Spinal cord injury produced by consistent mechanical displacement of the cord in rats: behavioral and histologic analysis J Neurotrauma 9 197 217
8. EC Benzel JA Lancon S Bairnsfather L Kesterson 1990 Effect of dosage and timing of administration of naloxone on outcome in the rat ventral compression model of spinal cord injury Neurosurgery 27 597 601 10.1097/00006123-199010000- 00016
9. AR Blight TI Cohen K Saito MP Heyes 1995 Quinolinic acid accumulation and functional deficits following experimental spinal cord injury Brain 118 735 752 10.1093/brain/118.3.735
10. MB Bracken WF Collins DF Freeman MJ Shepard FW Wagner RM Silten KG Hellenbrand J Ransohoff WE Hunt PL Perot Jr 1984 Efficacy of methylprednisolone in acute spinal cord injury JAMA 251 45 52 10.1001/jama.251.1.45 (Pubitemid 14212880)
11. MB Bracken MJ Shepard KG Hellenbrand WF Collins LS Leo DF Freeman FC Wagner ES Flamm HM Eisenberg JH Goodman 1985 Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study J Neurosurg 63 704 713
12. MB Bracken MJ Shepard WF Collins TR Holford W Young DS Baskin HM Eisenberg E Flamm L Leo-Summers J Maroon 1990 A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study N Engl J Med 322 1405 1411
13. MB Bracken MJ Shepard WF Collins Jr TR Holford DS Baskin HM Eisenberg E Flamm L Leo-Summers JC Maroon LF Marshall 1992 Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study J Neurosurg 76 23 31
14. MB Bracken MJ Shepard TR Holford L Leo-Summers EF Aldrich M Fazl M Fehlings DL Herr PW Hitchon LF Marshall RP Nockels V Pascale PL Perot Jr J Piepmeier VK Sonntag F Wagner JE Wilberger HR Winn W Young 1997 Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study JAMA 277 1597 1604 10.1001/jama.277.20.1597
15. MB Bracken MJ Shepard TR Holford L Leo-Summers EF Aldrich M Fazl MG Fehlings DL Herr PW Hitchon LF Marshall RP Nockels V Pascale PL Perot Jr J Piepmeier VK Sonntag F Wagner JE Wilberger HR Winn W Young 1998 Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial J Neurosurg 89 699 706
16. R Brambilla V Bracchi-Ricard WH Hu B Frydel A Bramwell S Karmally EJ Green JR Bethea 2005 Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury J Exp Med 202 145 156 10.1084/jem.20041918 (Pubitemid 41002917)
17. CM Brodmerkel R Huber M Covington S Diamond L Hall R Collins L Leffet K Gallagher P Feldman P Collier M Stow X Gu F Baribaud N Shin B Thomas T Burn G Hollis S Yeleswaram K Solomon S Friedman A Wang CB Xue RC Newton P Scherle K Vaddi 2005 Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344 J Immunol 175 5370 5378
18. KR Byrnes RW Waynant IK Ilev X Wu L Barna K Smith R Heckert H Gerst JJ Anders 2005 Light promotes regeneration and functional recovery and alters the immune response after spinal cord injury Lasers Surg Med 36 171 185 10.1002/lsm.20143
19. SJ Campbell PM Hughes JP Iredale DC Wilcockson S Waters F Docagne VH Perry DC Anthony 2003 CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury FASEB J 17 1168 1170
20. SJ Campbell VH Perry FJ Pitossi AG Butchart M Chertoff S Waters R Dempster DC Anthony 2005 Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver Am J Pathol 166 1487 1497
21. CC Chan 2008 Inflammation: beneficial or detrimental after spinal cord injury? Recent Pat CNS Drug Discov 3 189 199 10.2174/157488908786242434
22. D Čížková J Rosocha I Vanický S Jergová M Čízek 2006 Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat Cell Mol Neurobiol 26 1167 1180
23. I Damon PM Murphy B Moss 1998 Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog Proc Natl Acad Sci USA 95 6403 6407 10.1073/pnas.95.11.6403 (Pubitemid 28249025)
24. GV De Lucca UT Kim BJ Vargo JV Duncia JB Santella 3rd DS Gardner C Zheng A Liauw Z Wang G Emmett DA Wacker PK Welch M Covington NC Stowell EA Wadman AM Das P Davies S Yeleswaram DM Graden KA Solomon RC Newton GL Trainor CP Decicco SS Ko 2005 Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency J Med Chem 48 2194 2211 10.1021/jm049530m (Pubitemid 40396347)
25. MJ DeVivo 1997 Causes and costs of spinal cord injury in the US Spinal Cord 35 809 813 10.1038/sj.sc.3100501
26. I Dusart ME Schwab 1994 Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord Eur J NeuroSci 6 712 724 10.1111/j.1460-9568.1994.tb00983.x
27. MP Dwyer Y Yu J Chao C Aki J Chao P Biju V Girijavallabhan D Rindgen R Bond R Mayer-Ezel J Jakway RW Hipkin J Fossetta W Gonsiorek H Bian X Fan C Terminelli J Fine D Lundell JR Merritt LL Rokosz B Kaiser G Li W Wang T Stauffer L Ozgur J Baldwin AG Taveras 2006 Discovery of 2-hydroxy-N, N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3, 4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2/CXCR1 receptor antagonist J Med Chem 49 7603 7606 10.1021/jm0609622 (Pubitemid 46033652)
28. HF Egberink E De Clercq AL Van Vliet J Balzarini GJ Bridger G Henson MC Horzinek D Schols 1999 Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication J Virol 73 6346 6352
29. E Eidelberg E Staten CJ Watkins JS Smith 1976 Treatment of experimental spinal cord injury in ferrets Surg Neurol 6 243 246
30. JW Fawcett RA Asher 1999 The glial scar and central nervous system repair Brain Res Bull 49 377 391 10.1016/S0361-9230(99)00072-6 (Pubitemid 29385505)
31. MG Fehlings 2001 Editorial: Recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy Spine 26 24S S56 S57 10.1097/00007632-200112151-00012
32. K Fouad V Dietz ME Schwab 2001 Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors Brain Res Brain Res Rev 36 204 212 10.1016/S0165-0173(01)00096-0 (Pubitemid 33020750)
33. K Gale H Kerasidis JR Wrathall 1985 Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment Exp Neurol 88 123 126 10.1016/0014-4886(85)90118-9 (Pubitemid 15114489)
34. RP Gladue LA Tylaska WH Brissette PD Lira JC Kath CS Poss MF Brown TJ Paradis MJ Conklyn KT Ogborne MA McGlynn BM Lillie AP DiRico EN Mairs EB McElroy WH Martin IA Stock RM Shepard HJ Showell K Neote 2003 CP-481, 715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases J Biol Chem 278 40473 40480 10.1074/jbc.M306875200 (Pubitemid 37280857)
35. J Glaser R Gonzalez VM Perreau CW Cotman HS Keirstead 2004 Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury J Neurosci Res 77 701 708 10.1002/jnr.20204 (Pubitemid 39194611)
36. J Glaser R Gonzalez E Sadr HS Keirstead 2006 Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury J Neurosci Res 84 724 734 10.1002/jnr.20982 (Pubitemid 44366674)
37. R Gonzalez J Glaser MT Liu TE Lane HS Keirstead 2003 Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury Exp Neurol 184 456 463 10.1016/S0014-4886(03)00257-7 (Pubitemid 37444053)
38. R Gonzalez MJ Hickey JM Espinosa G Nistor TE Lane HS Keirstead 2007 Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice Regen Med 2 771 783 10.2217/17460751.2.5.771 (Pubitemid 47554831)
39. JA Gruner 1992 A monitored contusion model of spinal cord injury in the rat J Neurotrauma 9 123 128
40. ON Hausmann 2003 Post-traumatic inflammation following spinal cord injury Spinal Cord 41 369 378 10.1038/sj.sc.3101483 (Pubitemid 36819586)
41. E Hedlund MP Hefferan M Marsala O Isacson 2007 Cell therapy and stem cells in animal models of motor neuron disorders Eur J NeuroSci 26 1721 1737 10.1111/j.1460-9568.2007.05780.x (Pubitemid 47493182)
42. MP Hefferan T Fuchigami M Marsala 2006 Development of baclofen tolerance in a rat model of chronic spasticity and rigidity Neurosci Lett 403 195 200 10.1016/j.neulet.2006.04.048 (Pubitemid 43963261)
43. CE Heise A Pahuja SC Hudson MS Mistry AL Putnam MM Gross PA Gottlieb WS Wade M Kiankarimi D Schwarz P Crowe A Zlotnik DG Alleva 2005 Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist J Pharmacol Exp Ther 313 1263 1271 10.1124/jpet.105.083683 (Pubitemid 40727031)
44. S Hiruma K Otsuka T Satou S Hashimoto 1999 Simple and reproducible model of rat spinal cord injury induced by a controlled cortical impact device Neurol Res 21 313 323
45. A Holtz B Nystrom B Gerdin 1990 Relation between spinal cord blood flow and functional recovery after blocking weight-induced spinal cord injury in rats Neurosurgery 26 952 957 10.1097/00006123-199006000-00005
46. R Horuk C Clayberger AM Krensky Z Wang HJ Grone C Weber KS Weber PJ Nelson K May M Rosser L Dunning M Liang B Buckman A Ghannam HP Ng I Islam JG Bauman GP Wei S Monahan W Xu RM Snider MM Morrissey J Hesselgesser HD Perez 2001 A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection J Biol Chem 276 4199 4204 10.1074/jbc.M007457200
47. H Hugenholtz 2003 Methylprednisolone for acute spinal cord injury: not a standard of care CMAJ 168 1145 1146
48. RJ Hurlbert 2000 Methylprednisolone for acute spinal cord injury: an inappropriate standard of care J Neurosurg 93 1 7
49. M Imai M Watanabe K Suyama T Osada D Sakai H Kawada M Matsumae J Mochida 2008 Delayed accumulation of activated macrophages and inhibition of remyelination after spinal cord injury in an adult rodent model J Neurosurg Spine 8 58 66 10.3171/SPI-08/01/058
50. H Jayasuriya KB Herath JG Ondeyka JD Polishook GF Bills AW Dombrowski MS Springer S Siciliano L Malkowitz M Sanchez Z Guan S Tiwari DW Stevenson RP Borris SB Singh 2004 Isolation and structure of antagonists of chemokine receptor (CCR5) J Nat Prod 67 1036 1038 10.1021/np049974l (Pubitemid 38823341)
51. C Ji J Zhang M Dioszegi S Chiu E Rao A Derosier N Cammack M Brandt S Sankuratri 2007 CCR5 small-molecule antagonists and monoclonal antibodies exert potent synergistic antiviral effects by cobinding to the receptor Mol Pharmacol 72 18 28 10.1124/mol.107.035055 (Pubitemid 46998521)
52. TB Jones RP Hart PG Popovich 2005 Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury J Neurosci 25 6576 6583 10.1523/JNEUROSCI.0305-05.2005 (Pubitemid 40995289)
53. BA Kakulas 1987 The clinical neuropathology of spinal cord injury: a guide to the future Paraplegia 25 212 216
54. GS Kauffman PS Watson WA Nugent 2006 Strategy for the enantioselective synthesis of trans-2, 4-disubstituted piperidines: application to the CCR3 antagonist IS811 J Org Chem 71 8975 8977 10.1021/jo0616963 (Pubitemid 44721978)
55. RJ Kavanagh PC Kam 2001 Lazaroids: efficacy and mechanism of action of the 21-aminosteroids in neuroprotection Br J Anaesth 86 110 119 10.1093/bja/86.1.110 (Pubitemid 32015592)
56. S Kawa S Kimura S Hakomori Y Igarashi 1997 Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate FEBS Lett 420 196 200 10.1016/S0014-5793(97)01516-0 (Pubitemid 28037240)
57. G Keilhoff F Stang A Goihl G Wolf H Fansa 2006 Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination Cell Mol Neurobiol 26 1235 1252 10.1007/s10571-006-9029-9 (Pubitemid 44924044)
58. M Khan R Griebel 1983 Acute spinal cord injury in the rat: comparison of three experimental techniques Can J Neurol Sci 10 161 165
59. TN Kledal MM Rosenkilde F Coulin G Simmons AH Johnsen S Alouani CA Power HR Luttichau J Gerstoft PR Clapham I Clark-Lewis TN Wells TW Schwartz 1997 A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus Science 277 1656 1659 10.1126/science.277.5332.1656 (Pubitemid 27446226)
60. T Kunihara S Sasaki N Shiiya H Ishikura Y Kawarada A Matsukawa K Yasuda 2000 Lazaroid reduces production of IL-8 and IL-1receptor antagonist in ischemic spinal cord injury Ann Thorac Surg 69 792 798 10.1016/S0003-4975(99)01413-7 (Pubitemid 30184699)
61. T Kuppens W Herrebout B Van Der Veken D Corens A De Groot J Doyon G Van Lommen P Bultinck 2006 Elucidation of the absolute configuration of JNJ-27553292, a CCR2 receptor antagonist, by vibrational circular dichroism analysis of two precursors Chirality 18 609 620 10.1002/chir.20297 (Pubitemid 44576602)
62. YL Lee K Shih P Bao RS Ghirnikar LF Eng 2000 Cytokine chemokine expression in contused rat spinal cord Neurochem Int 36 417 425 10.1016/S0197-0186(99)00133-3 (Pubitemid 30101583)
63. F Li X Zhang JR Gordon 2002 CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8 Biochem Biophys Res Commun 293 939 944 10.1016/S0006-291X(02)00318-2 (Pubitemid 34694131)
64. M Ma T Wei L Boring IF Charo RM Ransohoff LB Jakeman 2002 Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion J Neurosci Res 68 691 702 10.1002/jnr.10269 (Pubitemid 34594986)
65. K Marks RM Gulick 2004 New antiretroviral agents for the treatment of HIV infection Curr HIV/AIDS Rep 1 82 88 10.1007/s11904-004-0012-0
66. SH Martin JR Bloedel 1973 Evaluation of experimental spinal cord injury using cortical evoked potentials J Neurosurg 39 75 81
67. H Miyazaki V Patel H Wang RK Edmunds JS Gutkind WA Yeudall 2006 Down-regulation of CXCL5 inhibits squamous carcinogenesis Cancer Res 66 4279 4284 10.1158/0008-5472.CAN-05-4398
68. T Morokata K Suzuki Y Masunaga K Taguchi K Morihira I Sato M Fujii S Takizawa Y Torii N Yamamoto M Kaneko T Yamada K Takahashi Y Shimizu 2006 A novel, selective, and orally available antagonist for CC chemokine receptor 3 J Pharmacol Exp Ther 317 244 250 10.1124/jpet.105.097048
69. CA Mueller HJ Schluesener S Conrad T Pietsch JM Schwab 2006 Spinal cord injury-induced expression of the immune-regulatory chemokine interleukin-16 caused by activated microglia/macrophages and CD8 + cells J Neurosurg Spine 4 233 240 10.3171/spi.2006.4.3.233 (Pubitemid 47325475)
70. RJ Nibbs TW Salcedo JD Campbell XT Yao Y Li B Nardelli HS Olsen TS Morris AE Proudfoot VP Patel GJ Graham 2000 C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap J Immunol 164 1488 1497
71. GC Nicholson RC Tennant DC Carpenter HM Sarau OM Kon PJ Barnes M Salmon RS Vessey R Tal-Singer TT Hansel 2007 A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist Pulm Pharmacol Ther 20 52 59 10.1016/j.pupt.2005.11.009 (Pubitemid 44648801)
72. B Nystrom JE Berglind 1988 Spinal cord restitution following compression injuries in rats Acta Neurol Scand 78 467 472 10.1111/j.1600-0404.1988.tb03689.x
73. A Palani S Shapiro JW Clader WJ Greenlee K Cox J Strizki M Endres BM Baroudy 2001 Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyl]-1'-[(2,4- dimethyl-3-pyridinyl)carbonyl]-4'-methyl-1, 4'-bipiperidine N-oxide (SCH 351125): an orally bioavailable human CCR5 antagonist for the treatment of HIV infection J Med Chem 44 3339 3342 10.1021/jm015526o (Pubitemid 32947898)
74. V Petkovic C Moghini S Paoletti M Uguccioni B Gerber 2004 Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role J Biol Chem 279 23357 23363 10.1074/jbc.M309283200 (Pubitemid 38685645)
75. PG Popovich P Wei BT Stokes 1997 Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats J Comp Neurol 377 443 464 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>;3.0.CO;2-S
76. K Princen S Hatse K Vermeire S Aquaro E De Clercq LO Gerlach M Rosenkilde TW Schwartz R Skerlj G Bridger D Schols 2004 Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist J Virol 78 12996 13006 10.1128/JVI.78.23.12996-13006.2004 (Pubitemid 39507807)
77. AE Proudfoot CA Power AJ Hoogewerf MO Montjovent F Borlat RE Offord TN Wells 1996 Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist J Biol Chem 271 2599 2603 10.1074/jbc.271.5.2599 (Pubitemid 26047869)
78. JR Pruitt DG Batt DA Wacker LL Bostrom SK Booker E McLaughlin GC Houghton JG Varnes DD Christ M Covington AM Das P Davies D Graden I Kariv Y Orlovsky NC Stowell KG Vaddi EA Wadman PK Welch S Yeleswaram KA Solomon RC Newton CP Decicco PH Carter SS Ko 2007 CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity Bioorg Med Chem Lett 17 2992 2997 10.1016/j.bmcl.2007.03.065 (Pubitemid 46702643)
79. A Rappert I Bechmann T Pivneva J Mahlo K Biber C Nolte AD Kovac C Gerard HW Boddeke R Nitsch H Kettenmann 2004 CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion J Neurosci 24 8500 8509 10.1523/JNEUROSCI.2451-04.2004 (Pubitemid 39313773)
80. R Ravikumar G Flora JW Geddes B Hennig M Toborek 2004 Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma Brain Res Mol Brain Res 124 188 198 10.1016/j.molbrainres.2004.02.018 (Pubitemid 38591571)
81. F Renault-Mihara S Okada S Shibata M Nakamura Y Toyama H Okano 2008 Spinal cord injury: emerging beneficial role of reactive astrocytes' migration Int J Biochem Cell Biol 40 1649 1653 10.1016/j.biocel.2008.03.009
82. T Rice J Larsen S Rivest VW Yong 2007 Characterization of the early neuroinflammation after spinal cord injury in mice J Neuropathol Exp Neurol 66 184 195 10.1097/01.jnen.0000248552.07338.7f (Pubitemid 46673274)
83. I Sabroe MJ Peck BJ Van Keulen A Jorritsma G Simmons PR Clapham TJ Williams JE Pease 2000 A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry J Biol Chem 275 25985 25992 10.1074/jbc.M908864199 (Pubitemid 30676638)
84. L Schnell S Fearn H Klassen ME Schwab VH Perry 1999 Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord Eur J NeuroSci 11 3648 3658 10.1046/j.1460-9568.1999.00792.x (Pubitemid 29484261)
85. JM Schwab K Brechtel CA Mueller V Failli HP Kaps SK Tuli HJ Schluesener 2006 Experimental strategies to promote spinal cord regeneration-an integrative perspective Prog Neurobiol 78 91 116 10.1016/j.pneurobio.2005.12.004 (Pubitemid 43290717)
86. G Simmons PR Clapham L Picard RE Offord MM Rosenkilde TW Schwartz R Buser TN Wells AE Proudfoot 1997 Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist Science 276 276 279 10.1126/science.276.5310.276 (Pubitemid 27172690)
87. P Steinberger J Andris-Widhopf B Buhler BE Torbett CF Barbas 3rd 2000 Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion Proc Natl Acad Sci USA 97 805 810 10.1073/pnas.97.2.805 (Pubitemid 30070391)
88. P Steinberger JK Sutton C Rader M Elia CF Barbas 3rd 2000 Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization J Biol Chem 275 36073 36078 10.1074/jbc.M002765200 (Pubitemid 30841153)
89. CC Stichel HW Muller 1998 The CNS lesion scar: new vistas on an old regeneration barrier Cell Tissue Res 294 1 9 10.1007/s004410051151 (Pubitemid 28442277)
90. BT Stokes DH Noyes DL Behrmann 1992 An electromechanical spinal injury technique with dynamic sensitivity J Neurotrauma 9 187 195
91. M Takenaga Y Ohta Y Tokura A Hamaguchi M Nakamura H Okano R Igarashi 2006 Lecithinized superoxide dismutase (PC-SOD) improved spinal cord injury-induced motor dysfunction through suppression of oxidative stress and enhancement of neurotrophic factor production J Control Release 110 283 289 10.1016/j.jconrel.2005.10.022 (Pubitemid 41827481)
92. H Tamamura M Imai T Ishihara M Masuda H Funakoshi H Oyake T Murakami R Arakaki H Nakashima A Otaka T Ibuka M Waki A Matsumoto N Yamamoto N Fujii 1998 Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5, 12), Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection Bioorg Med Chem 6 1033 1041 10.1016/S0968-0896(98)00061-3 (Pubitemid 28464534)
93. BL Tang CB Low 2007 Genetic manipulation of neural stem cells for transplantation into the injured spinal cord Cell Mol Neurobiol 27 75 85 10.1007/s10571-006-9119-8 (Pubitemid 46169896)
94. IM Tarlov H Klinger S Vitale 1953 Spinal cord compression studies. I. Experimental techniques to produce acute and gradual compression AMA Arch Neurol Psychiatry 70 813 819
95. CH Tator 1998 Biology of neurological recovery and functional restoration after spinal cord injury Neurosurgery 42 696 707 10.1097/00006123-199804000- 00007 (Pubitemid 28208353)
96. CH Tator L Deecke 1973 Studies of the treatment and pathophysiology of acute spinal cord injury in primates Paraplegia 10 344 345
97. T Tonai K Shiba Y Taketani Y Ohmoto K Murata M Muraguchi H Ohsaki E Takeda T Nishisho 2001 A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats J Neurochem 78 1064 1072 10.1046/j.1471-4159.2001.00488.x (Pubitemid 32823155)
98. CL Tremblay F Giguel TC Chou H Dong K Takashima MS Hirsch 2005 TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro Antivir Ther 10 967 968
99. CL Tremblay F Giguel Y Guan TC Chou K Takashima MS Hirsch 2005 TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro Antimicrob Agents Chemother 49 3483 3485 10.1128/AAC.49.8.3483-3485.2005 (Pubitemid 41060599)
100. EE Ubogu MB Cossoy RM Ransohoff 2006 The expression and function of chemokines involved in CNS inflammation Trends Pharmacol Sci 27 48 55 10.1016/j.tips.2005.11.002 (Pubitemid 43063124)
101. I Vanicky L Urdzikova K Saganova D Cizkova J Galik 2001 A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat J Neurotrauma 18 1399 1407 10.1089/08977150152725687
102. TC Walser S Rifat X Ma N Kundu C Ward O Goloubeva MG Johnson JC Medina TL Collins AM Fulton 2006 Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer Cancer Res 66 7701 7707 10.1158/0008-5472. CAN-06-0709 (Pubitemid 44289229)
103. C Watson S Jenkinson W Kazmierski T Kenakin 2005 The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor Mol Pharmacol 67 1268 1282 10.1124/mol.104.008565 (Pubitemid 40410427)
104. JR White JM Lee PR Young RP Hertzberg AJ Jurewicz MA Chaikin K Widdowson JJ Foley LD Martin DE Griswold HM Sarau 1998 Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration J Biol Chem 273 10095 10098 10.1074/jbc.273.17.10095 (Pubitemid 28227606)
105. JR White JM Lee K Dede CS Imburgia AJ Jurewicz G Chan JA Fornwald D Dhanak LT Christmann MG Darcy KL Widdowson JJ Foley DB Schmidt HM Sarau 2000 Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration J Biol Chem 275 36626 36631 10.1074/jbc.M006613200 (Pubitemid 32002063)
106. X Wu J Fan X Wang J Zhou S Qiu Y Yu Y Liu Z Tang 2007 Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion Biochem Biophys Res Commun 355 866 871 10.1016/j.bbrc.2007.01.199 (Pubitemid 46366907)
107. L Yang G Butora RX Jiao A Pasternak C Zhou WH Parsons SG Mills PP Vicario JM Ayala MA Cascieri M MacCoss 2007 Discovery of 3-piperidinyl-1- cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists J Med Chem 50 2609 2611 10.1021/jm070166b (Pubitemid 46896068)